Rosenke K, Adjemian J, Munster VJ, Marzi A, Falzarano D, et al.
2016-08-15 • Clinical Infectious Diseases
2016-08-15 • Clinical Infectious Diseases
BACKGROUND The ongoing Ebola outbreak in West Africa has resulted in 28 646 suspected, probable, and confirmed Ebola virus infections. Nevertheless, malaria remains a large public he...
Swannet S, Decroo T, de Castro SMTL, Rose C, Giuliani R, et al.
2017-07-22 • International Health
2017-07-22 • International Health
INTRODUCTION Viral load (VL) monitoring for people on antiretroviral therapy (ART) is extremely challenging in resource-limited settings. We assessed the VL testing scale-up in six M...
Prisons are high-risk settings for COVID-19 and present specific challenges for prevention and control. We describe a COVID-19 outbreak in a large prison in Milan between 20 February and...
Pulido Tarquino IA, Venables E, de Amaral Fidelis JM, Giuliani R, Decroo T
2019-06-17 • PLOS One
2019-06-17 • PLOS One
BACKGROUND: HIV prevalence in Mozambique is estimated to be 13.2%. Routine viral load for HIV monitoring was first implemented in the rural area of Tete in 2014. Programmatic data sh...
Chertow DS, Kleine C, Edwards JK, Scaini R, Giuliani R, et al.
2014-11-05 • New England Journal of Medicine
2014-11-05 • New England Journal of Medicine
In resource-limited areas, isolation of the sick from the population at large has been the cornerstone of control of Ebola virus disease (EVD) since the virus was discovered in 1976.(1) ...
Huerga H, Shiferie F, Grebe E, Giuliani R, Farhat JB, et al.
2017-09-29 • BMC Infectious Diseases
2017-09-29 • BMC Infectious Diseases
Accurately identifying individuals who are on antiretroviral therapy (ART) is important to determine ART coverage and proportion on ART who are virally suppressed. ART is also included i...
